Molecular Diagnostics Market : Trends , Opportunities and Market Forecasts

1
MarketsandMarkets Presents
Global Molecular Diagnostics Market worth 8.1
Billion by 2017
2

• The new market research report Molecular
  Diagnostics Market - Technologies (PCR, DNA
  Sequencing, Microarray, Spectroscopy),
  Applications (Virology/Infectious Diseases,
  Cancer/Oncology, Genetic Testing) - Global
  Opportunities, Competitor Analysis Forecasts to
  2017 analyzes and studies the major market
  drivers, restraints, and opportunities in North
  America, Europe, Asia, and Rest of the World.
• Browse 130 market data tables/ figures spread
  through 391 pages and in-depth TOC of Molecular
  Diagnostics Market - Technologies, Applications -
  Global Opportunities, Competitor Analysis
  Forecasts to 2017.
• http//www.marketsandmarkets.com/Market-Reports/mo
  lecular-diagnostic-market-833.html

3

• This report studies the global molecular
  diagnostics market, with forecast to 2017.
• Molecular diagnostics (MDx) is a new class of
  diagnostic tests that identify nucleic acids or
  proteins to test the status of a disease. These
  nucleic acids or proteins, which belong to
  individual patients or foreign organisms, help
  determine a specific therapy, or risk of
  developing a specific disease, or other health
  conditions. MDx is the fastest growing segment
  within the in-vitro diagnostic (IVD) space,
  driven by accuracy, high sensitivity, fast
  turnaround time, easy workflow, and
  cost-effective testing. Owing to these factors,
  the molecular diagnostics market crossed 4.8
  billion in 2011, and is poised to grow at a CAGR
  of 9.1 in the next five years to reach 8.1
  billion.
• Molecular diagnostics has applications in
  infectious disease molecular testing, oncology,
  blood screening, genetic testing, DNA
  fingerprinting (e.g., paternity testing, forensic
  testing), microbiology, tissue typing, and food
  pathogen detection testing. The booming MDx areas
  are molecular tests for womens health, oncology,
  and organ transplant testing.

4

• Factors like increase in awareness and acceptance
  of personalized medicine, advancements in
  molecular techniques, and increasing investments
  in proteomics and genomics research will spur the
  molecular diagnostics market in the future. Yet,
  reimbursement issues for non-coded tests and
  complex regulatory framework will restrict the
  growth of this market.
• Although the market for molecular diagnostics is
  fragmented with more than 500 companies, the most
  prominent players are Roche Diagnostics
  (Switzerland), Novartis (Switzerland), Gen-Probe
  (U.S.), Qiagen (The Netherlands), Abbott
  Diagnostics (U.S.), Becton Dickinson (U.S.) and
  Cepheid (U.S.), to name a few.

5
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets
6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.